BALPHARMA.BOBALPHARMA.BOBSE
Loading
Interest Expense Over TimeStrong
Percentile Rank93
3Y CAGR+16.3%
5Y CAGR+6.6%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+16.3%/yr
vs -4.4%/yr prior
5Y CAGR
+6.6%/yr
Recent acceleration
Acceleration
+20.7pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $167.12M | -0.8% |
| 2025 | $168.54M | +10.5% |
| 2024 | $152.58M | +43.6% |
| 2023 | $106.23M | +0.8% |
| 2022 | $105.42M | -13.3% |
| 2021 | $121.58M | -4.5% |
| 2020 | $127.32M | -0.1% |
| 2019 | $127.40M | +37.4% |
| 2018 | $92.72M | +9.3% |
| 2017 | $84.87M | - |